Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2810423A 18Rik | |
AK013141 |
10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810423A18 product:unclassifiable, full insert sequence [AK013141] |
KLA | 1.03 |
.97 |
1.07 |
.95 |
1.09 |
1.26 |
1.38 |
| ATP | .96 |
.98 |
1.09 |
1.02 |
2.18 |
2.30 |
1.52 |
| KLA/ATP | .99 |
.97 |
.94 |
.75 |
1.93 |
3.39 |
2.34 |
|
4930438A 08Rik | |
XM_001477470 |
gb|PREDICTED: Mus musculus RIKEN cDNA 4930438A08 gene (4930438A08Rik), mRNA [XM_001477470] |
KLA | 1.78 |
1.45 |
1.69 |
1.62 |
1.69 |
1.48 |
1.31 |
| ATP | 1.07 |
1.04 |
1.24 |
1.13 |
1.13 |
1.61 |
1.67 |
| KLA/ATP | 1.83 |
1.46 |
1.58 |
1.30 |
1.43 |
1.36 |
1.95 |
|
Abat | |
AK083062 |
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530041H11 product:hypothetical protein, full insert sequence. [AK083062] |
KLA | 1.01 |
1.09 |
.97 |
.99 |
1.03 |
1.02 |
1.06 |
| ATP | .96 |
.99 |
1.00 |
1.11 |
1.04 |
.98 |
1.06 |
| KLA/ATP | 1.06 |
1.03 |
.96 |
1.06 |
1.10 |
1.06 |
.96 |
|
Abat | |
NM_172961 |
4-aminobutyrate aminotransferase (Abat), nuclear gene encoding mitochondrial protein, mRNA [NM_172961] |
KLA | 1.03 |
.96 |
.97 |
1.00 |
.92 |
.97 |
.96 |
| ATP | .97 |
.93 |
1.07 |
1.04 |
.97 |
.99 |
.98 |
| KLA/ATP | 1.03 |
1.01 |
1.00 |
.98 |
.94 |
.89 |
.97 |
|
Acy3 | |
NM_027857 |
aspartoacylase (aminoacylase) 3 (Acy3), mRNA [NM_027857] |
KLA | .98 |
1.04 |
.96 |
1.06 |
.88 |
.89 |
.93 |
| ATP | 1.11 |
1.06 |
.99 |
1.20 |
1.07 |
.87 |
.98 |
| KLA/ATP | 1.04 |
1.01 |
.98 |
1.04 |
.94 |
.95 |
1.06 |
|
Adsl | |
NM_009634 |
adenylosuccinate lyase (Adsl), mRNA [NM_009634] |
KLA | .87 |
.93 |
.90 |
.97 |
.82 |
.64 |
1.06 |
| ATP | 1.08 |
1.12 |
1.06 |
1.04 |
.80 |
.60 |
.86 |
| KLA/ATP | 1.02 |
.95 |
1.00 |
.86 |
.66 |
.49 |
.49 |
|
Adss | |
NM_007422 |
adenylosuccinate synthetase, non muscle (Adss), mRNA [NM_007422] |
KLA | 1.21 |
1.15 |
.96 |
.70 |
.35 |
.24 |
.51 |
| ATP | .93 |
1.08 |
.97 |
1.14 |
.93 |
.75 |
.47 |
| KLA/ATP | 1.24 |
1.19 |
.87 |
.99 |
.56 |
.40 |
.33 |
|
Adssl1 | |
NM_007421 |
adenylosuccinate synthetase like 1 (Adssl1), mRNA [NM_007421] |
KLA | .67 |
.67 |
.53 |
.51 |
.32 |
.17 |
.20 |
| ATP | .87 |
.76 |
.96 |
.74 |
.73 |
.38 |
.60 |
| KLA/ATP | .58 |
.59 |
.64 |
.48 |
.62 |
.49 |
.37 |
|
Agxt | |
NM_016702 |
alanine-glyoxylate aminotransferase (Agxt), mRNA [NM_016702] |
KLA | 1.01 |
.95 |
.96 |
1.05 |
1.01 |
.98 |
.94 |
| ATP | .95 |
1.03 |
1.03 |
.99 |
.97 |
.96 |
1.05 |
| KLA/ATP | .94 |
.99 |
1.01 |
1.01 |
.96 |
.92 |
.96 |
|
Agxt2 | |
NM_001031851 |
alanine-glyoxylate aminotransferase 2 (Agxt2), nuclear gene encoding mitochondrial protein, mRNA [NM_001031851] |
KLA | .98 |
.99 |
1.04 |
1.05 |
.93 |
1.01 |
1.05 |
| ATP | 1.02 |
1.03 |
1.03 |
1.06 |
1.01 |
.96 |
.97 |
| KLA/ATP | 1.05 |
.98 |
.99 |
1.04 |
.99 |
1.02 |
1.01 |
|
Aldh4a1 | |
NM_175438 |
aldehyde dehydrogenase 4 family, member A1 (Aldh4a1), nuclear gene encoding mitochondrial protein, mRNA [NM_175438] |
KLA | .90 |
.85 |
.85 |
.82 |
.87 |
.94 |
.87 |
| ATP | 1.05 |
1.16 |
1.03 |
1.02 |
.81 |
.83 |
1.00 |
| KLA/ATP | .92 |
.88 |
.84 |
.92 |
.82 |
.88 |
.91 |
|
Aldh5a1 | |
AK051603 |
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130059J11 product:succinate-semialdehyde dehydrogenase (EC 1.2.1.24) (fragment) homolog [Rattus norvegicus], full insert sequence. [AK051603] |
KLA | 1.04 |
.99 |
1.06 |
1.03 |
1.01 |
1.09 |
1.08 |
| ATP | .94 |
.93 |
1.01 |
1.04 |
1.06 |
1.10 |
1.02 |
| KLA/ATP | 1.00 |
1.03 |
.83 |
1.02 |
1.06 |
1.03 |
1.04 |
|
Aldh5a1 | |
NM_172532 |
aldhehyde dehydrogenase family 5, subfamily A1 (Aldh5a1), mRNA [NM_172532] |
KLA | .99 |
.98 |
.84 |
.95 |
.81 |
.63 |
.52 |
| ATP | .92 |
.83 |
1.21 |
1.06 |
.90 |
.70 |
.57 |
| KLA/ATP | .92 |
.96 |
1.24 |
.95 |
.89 |
.62 |
.59 |
|
Asl | |
NM_133768 |
argininosuccinate lyase (Asl), mRNA [NM_133768] |
KLA | .88 |
.92 |
.83 |
.75 |
.78 |
.83 |
1.05 |
| ATP | 1.00 |
1.09 |
.93 |
1.21 |
1.02 |
.85 |
1.41 |
| KLA/ATP | .89 |
.96 |
.74 |
1.01 |
.81 |
.85 |
1.55 |
|
Asns | |
NM_012055 |
asparagine synthetase (Asns), mRNA [NM_012055] |
KLA | .89 |
.91 |
.75 |
.69 |
.53 |
.85 |
2.04 |
| ATP | .87 |
.80 |
1.06 |
.79 |
2.07 |
2.78 |
1.76 |
| KLA/ATP | .85 |
.80 |
.84 |
.58 |
1.02 |
1.08 |
.97 |
|
Aspa | |
NM_023113 |
aspartoacylase (Aspa), mRNA [NM_023113] |
KLA | 1.03 |
1.06 |
1.08 |
1.12 |
1.10 |
1.09 |
1.18 |
| ATP | 1.02 |
.94 |
1.08 |
1.09 |
.97 |
1.08 |
1.01 |
| KLA/ATP | 1.04 |
1.03 |
1.14 |
1.05 |
1.07 |
1.12 |
1.11 |
|
Ass1 | |
M31690 |
gb|Mouse argininosuccinate synthetase (Ass) mRNA, complete cds. [M31690] |
KLA | 4.67 |
5.37 |
6.47 |
6.68 |
8.75 |
9.43 |
8.52 |
| ATP | 1.17 |
1.32 |
1.27 |
1.78 |
2.00 |
6.66 |
7.95 |
| KLA/ATP | 5.78 |
6.01 |
5.41 |
6.67 |
6.73 |
8.48 |
13.11 |
|
Ass1 | |
NM_007494 |
argininosuccinate synthetase 1 (Ass1), mRNA [NM_007494] |
KLA | 4.88 |
5.58 |
7.14 |
7.84 |
10.68 |
11.29 |
9.93 |
| ATP | 1.12 |
1.29 |
1.28 |
1.75 |
2.04 |
7.76 |
9.44 |
| KLA/ATP | 5.70 |
6.62 |
5.49 |
8.11 |
6.90 |
9.65 |
16.23 |
|
Cad | |
NM_023525 |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (Cad), mRNA [NM_023525] |
KLA | .88 |
.82 |
.73 |
.65 |
.53 |
.46 |
.59 |
| ATP | 1.00 |
1.00 |
.94 |
.86 |
.74 |
.60 |
.67 |
| KLA/ATP | .86 |
.81 |
.76 |
.65 |
.55 |
.46 |
.44 |
|
Cps1 | |
AK028683 |
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732433M03 product:weakly similar to carbamoyl-phosphate synthase (glutamine-hydrolyzing) (EC 6.3.5.5) large chain [Schizosaccharomyces pombe], full insert sequence. [A |
KLA | .99 |
1.01 |
1.08 |
1.02 |
1.01 |
.96 |
1.05 |
| ATP | .96 |
1.00 |
.94 |
.97 |
.98 |
.98 |
1.05 |
| KLA/ATP | .97 |
1.09 |
1.04 |
.99 |
1.05 |
1.03 |
.96 |
|
Cps1 | |
AK028683 |
10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732433M03 product:weakly similar to carbamoyl-phosphate synthase (glutamine-hydrolyzing) (EC 6.3.5.5) large chain [Schizosaccharomyces pombe], full insert sequence. [AK |
KLA | 1.03 |
1.04 |
1.06 |
.96 |
1.08 |
1.08 |
1.03 |
| ATP | .99 |
.98 |
1.09 |
1.07 |
.97 |
1.02 |
1.09 |
| KLA/ATP | .98 |
1.00 |
.95 |
1.10 |
1.00 |
1.05 |
1.09 |
|
Ddo | |
AK019898 |
adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330420D20 product:similar to D-ASPARTATE OXIDASE (EC 1.4.3.1) (FRAGMENT) [Bos taurus], full insert sequence. [AK019898] |
KLA | 1.05 |
.99 |
.99 |
1.07 |
1.04 |
1.00 |
.99 |
| ATP | .98 |
1.04 |
.94 |
1.05 |
.98 |
1.03 |
1.01 |
| KLA/ATP | 1.02 |
.91 |
.98 |
1.01 |
1.05 |
1.01 |
1.01 |
|
Ddo | |
NM_027442 |
D-aspartate oxidase (Ddo), mRNA [NM_027442] |
KLA | 1.03 |
.93 |
1.02 |
.99 |
.93 |
1.03 |
1.07 |
| ATP | 1.01 |
.94 |
1.13 |
1.02 |
.99 |
1.00 |
1.02 |
| KLA/ATP | 1.03 |
1.04 |
1.10 |
1.02 |
1.11 |
.98 |
1.03 |
|
Gad1 | |
AK054554 |
10 days neonate olfactory brain cDNA, RIKEN full-length enriched library, clone:E530004P22 product:glutamic acid decarboxylase 1, full insert sequence. [AK054554] |
KLA | 1.03 |
1.00 |
1.00 |
1.00 |
1.00 |
.98 |
1.10 |
| ATP | 1.03 |
.91 |
1.01 |
1.05 |
.99 |
.97 |
1.08 |
| KLA/ATP | .97 |
.99 |
.99 |
1.10 |
1.02 |
1.09 |
.96 |
|
Gad1 | |
NM_008077 |
glutamic acid decarboxylase 1 (Gad1), mRNA [NM_008077] |
KLA | 1.03 |
.99 |
1.00 |
1.01 |
1.01 |
.97 |
.99 |
| ATP | 1.02 |
1.02 |
1.01 |
.99 |
1.02 |
1.03 |
.98 |
| KLA/ATP | .96 |
1.03 |
1.04 |
.99 |
.99 |
1.04 |
1.01 |
|
Gad2 | |
NM_008078 |
glutamic acid decarboxylase 2 (Gad2), mRNA [NM_008078] |
KLA | 1.03 |
1.07 |
1.11 |
1.11 |
1.04 |
.99 |
1.07 |
| ATP | .97 |
.99 |
1.02 |
1.02 |
1.01 |
.95 |
.97 |
| KLA/ATP | 1.05 |
1.08 |
1.04 |
1.01 |
1.00 |
1.06 |
1.00 |
|
Gfpt1 | |
NM_013528 |
glutamine fructose-6-phosphate transaminase 1 (Gfpt1), mRNA [NM_013528] |
KLA | 1.65 |
1.73 |
1.88 |
1.89 |
1.81 |
1.81 |
2.11 |
| ATP | 1.13 |
1.24 |
1.25 |
1.43 |
2.76 |
2.99 |
3.85 |
| KLA/ATP | 1.78 |
2.02 |
1.88 |
1.75 |
1.97 |
3.84 |
6.84 |
|
Gfpt2 | |
NM_013529 |
glutamine fructose-6-phosphate transaminase 2 (Gfpt2), mRNA [NM_013529] |
KLA | 1.28 |
1.31 |
1.50 |
1.32 |
1.18 |
1.25 |
1.11 |
| ATP | .98 |
1.00 |
1.05 |
1.72 |
2.72 |
2.21 |
1.07 |
| KLA/ATP | 1.34 |
1.42 |
1.38 |
2.19 |
2.19 |
1.93 |
1.54 |
|
Gls2 | |
NM_001033264 |
glutaminase 2 (liver, mitochondrial) (Gls2), nuclear gene encoding mitochondrial protein, mRNA [NM_001033264] |
KLA | 1.03 |
.98 |
1.02 |
.97 |
.98 |
.88 |
.80 |
| ATP | .94 |
1.01 |
1.04 |
1.08 |
1.26 |
1.20 |
.87 |
| KLA/ATP | .95 |
.98 |
1.15 |
1.02 |
1.29 |
.99 |
.87 |
|
Glud1 | |
NM_008133 |
glutamate dehydrogenase 1 (Glud1), mRNA [NM_008133] |
KLA | .70 |
.70 |
.63 |
.54 |
.52 |
.54 |
.59 |
| ATP | .96 |
.91 |
1.01 |
1.05 |
.96 |
.66 |
.47 |
| KLA/ATP | .67 |
.66 |
.61 |
.69 |
.70 |
.51 |
.27 |
|
Glul | |
NM_008131 |
glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131] |
KLA | .58 |
.54 |
.47 |
.41 |
.30 |
.31 |
.40 |
| ATP | .96 |
.99 |
1.46 |
2.55 |
2.16 |
2.88 |
1.34 |
| KLA/ATP | .57 |
.56 |
.83 |
1.52 |
1.27 |
1.20 |
.97 |
|
Glul | |
X16314 |
gb|M.musculus mRNA for glutamine synthetase. [X16314] |
KLA | .86 |
.95 |
.79 |
.87 |
.78 |
.99 |
.83 |
| ATP | .95 |
1.03 |
1.09 |
1.27 |
1.14 |
1.37 |
1.00 |
| KLA/ATP | .88 |
.97 |
.89 |
1.12 |
1.01 |
1.19 |
.91 |
|
Got1 | |
NM_010324 |
glutamate oxaloacetate transaminase 1, soluble (Got1), mRNA [NM_010324] |
KLA | .68 |
.70 |
.66 |
.56 |
.50 |
.57 |
.99 |
| ATP | 1.01 |
1.24 |
1.55 |
1.59 |
1.47 |
1.03 |
1.68 |
| KLA/ATP | .68 |
.71 |
.66 |
.77 |
1.13 |
2.33 |
1.89 |
|
Got2 | |
NM_010325 |
glutamate oxaloacetate transaminase 2, mitochondrial (Got2), nuclear gene encoding mitochondrial protein, mRNA [NM_010325] |
KLA | .84 |
.86 |
.88 |
.75 |
.75 |
.63 |
.61 |
| ATP | 1.02 |
1.12 |
.98 |
1.15 |
.98 |
.67 |
.86 |
| KLA/ATP | .92 |
.89 |
.75 |
.89 |
.68 |
.70 |
.77 |
|
Gpt | |
NM_182805 |
glutamic pyruvic transaminase, soluble (Gpt), mRNA [NM_182805] |
KLA | .82 |
.81 |
.80 |
.82 |
.78 |
.83 |
1.05 |
| ATP | 1.01 |
1.00 |
1.07 |
1.23 |
1.20 |
.77 |
1.01 |
| KLA/ATP | .85 |
.86 |
.93 |
1.01 |
1.32 |
.83 |
.97 |
|
Gpt2 | |
NM_173866 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 (Gpt2), mRNA [NM_173866] |
KLA | .82 |
.87 |
.84 |
.69 |
.64 |
.80 |
.91 |
| ATP | .97 |
1.08 |
1.06 |
.95 |
1.33 |
2.66 |
1.89 |
| KLA/ATP | .81 |
.83 |
.67 |
.70 |
1.07 |
2.66 |
1.63 |
|
Il4i1 | |
NM_010215 |
interleukin 4 induced 1 (Il4i1), mRNA [NM_010215] |
KLA | 13.98 |
13.74 |
14.90 |
14.92 |
13.89 |
12.12 |
3.25 |
| ATP | 1.02 |
.98 |
1.14 |
1.59 |
4.45 |
6.63 |
2.41 |
| KLA/ATP | 16.09 |
15.56 |
19.65 |
19.66 |
18.47 |
14.84 |
12.99 |
|
Lao1 | |
NM_133892 |
L-amino acid oxidase 1 (Lao1), mRNA [NM_133892] |
KLA | 1.03 |
1.03 |
1.04 |
1.00 |
.98 |
1.01 |
.98 |
| ATP | 1.01 |
1.03 |
1.02 |
.92 |
1.05 |
.98 |
.99 |
| KLA/ATP | 1.02 |
.96 |
1.04 |
.94 |
.96 |
.97 |
.97 |
|
Mm.30102
| |
142348692 |
Unknown |
KLA | 1.04 |
1.04 |
.97 |
1.07 |
1.02 |
.93 |
.90 |
| ATP | 1.06 |
.98 |
1.13 |
1.06 |
1.30 |
1.19 |
.78 |
| KLA/ATP | .94 |
1.05 |
1.13 |
1.05 |
1.24 |
1.12 |
.84 |
|
Mm.30384 7 | |
73661177 |
Unknown |
KLA | .94 |
1.00 |
1.07 |
1.05 |
.96 |
1.04 |
1.08 |
| ATP | 1.06 |
1.01 |
.98 |
1.02 |
.98 |
.99 |
1.01 |
| KLA/ATP | 1.03 |
.94 |
1.13 |
1.06 |
1.03 |
1.03 |
.99 |
|
Mm.44046 5 | |
164607131 |
Unknown |
KLA | .65 |
.56 |
.59 |
.51 |
.33 |
.20 |
.24 |
| ATP | 1.07 |
.90 |
1.30 |
2.88 |
3.61 |
4.46 |
1.07 |
| KLA/ATP | .60 |
.59 |
.95 |
2.38 |
2.99 |
2.31 |
.37 |
|
Nit2 | |
NM_023175 |
nitrilase family, member 2 (Nit2), mRNA [NM_023175] |
KLA | 1.33 |
1.29 |
1.35 |
1.24 |
1.13 |
.93 |
1.13 |
| ATP | 1.12 |
1.12 |
1.21 |
1.37 |
1.04 |
.66 |
.74 |
| KLA/ATP | 1.43 |
1.43 |
1.29 |
1.53 |
1.29 |
1.16 |
.62 |
|
Ppat | |
XM_896000 |
gb|PREDICTED: Mus musculus phosphoribosyl pyrophosphate amidotransferase, transcript variant 3 (Ppat), mRNA [XM_896000] |
KLA | .54 |
.49 |
.44 |
.40 |
.36 |
.46 |
.60 |
| ATP | .91 |
.96 |
1.03 |
.85 |
.83 |
.81 |
.67 |
| KLA/ATP | .49 |
.50 |
.52 |
.49 |
.65 |
.63 |
.37 |
|